24C Stock Chart & Stats
€2.83
€0.01(0.40%)
At close: 4:00 PM EST
€2.83
€0.01(0.40%)
Day’s Range― - ―
52-Week Range€2.18 - €3.38
Previous CloseN/A
Volume0.00
Average Volume (3M)162.00
Market Cap
€111.78M
Enterprise Value€1.06B
Total Cash (Recent Filing)€135.20M
Total Debt (Recent Filing)€9.40M
Price to Earnings (P/E)41.0
Beta0.30
Next Earnings
Jul 17, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.88
Shares Outstanding32,904,050
10 Day Avg. Volume200
30 Day Avg. Volume162
Financial Highlights & Ratios
PEG Ratio-1.27
Price to Book (P/B)3.12
Price to Sales (P/S)2.45
P/FCF Ratio21.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.13
Revenue Forecast (FY)€41.19M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage gives the company durable financial flexibility, lowering bankruptcy risk and enabling investment or acquisitions without heavy refinancing. A conservative balance sheet supports stability through equipment sales cycles and funds strategic initiatives over months.
Solid Operating ProfitabilitySustained operating margins indicate the core SGRT and positioning business converts revenue efficiently, supporting pricing power and reinvestment. Strong operating profitability provides a buffer against cyclical equipment demand and funds R&D and service capabilities long-term.
Recurring After-sales RevenueRecurring service and maintenance revenue from an installed base smooths cash flow and increases customer lifetime value. This business-model mix reduces reliance on one-time equipment sales and supports predictable revenue and follow-on upgrade opportunities over multiple quarters.
Bears Say
Declining TTM RevenueA multi-quarter revenue contraction weakens growth momentum and may limit scale benefits. Persistent revenue declines constrain reinvestment, reduce pricing leverage, and can force cost-cutting that harms long-term market share and product development.
Compressed Net MarginsLow net margin despite solid operating margin suggests weak below-the-line conversion (taxes, interest, non-operating items). This reduces return on equity and shareholder value creation, leaving less retained earnings to fund growth or withstand cost inflation.
Weakened Cash GenerationA sharp FCF decline and volatile operating cash flow erode financial flexibility, increasing reliance on external funding for capex or working capital. Weak cash conversion can force deferred maintenance, slower rollouts, or constrain service expansion over the coming quarters.
C-Rad AB Class B News
24C FAQ
What was C-Rad AB Class B’s price range in the past 12 months?
C-Rad AB Class B lowest stock price was €2.18 and its highest was €3.38 in the past 12 months.
What is C-Rad AB Class B’s market cap?
C-Rad AB Class B’s market cap is €111.78M.
When is C-Rad AB Class B’s upcoming earnings report date?
C-Rad AB Class B’s upcoming earnings report date is Jul 17, 2026 which is in 9 days.
How were C-Rad AB Class B’s earnings last quarter?
C-Rad AB Class B released its earnings results on May 06, 2026. The company reported €0.03 earnings per share for the quarter, beating the consensus estimate of €0.014 by €0.016.
Is C-Rad AB Class B overvalued?
According to Wall Street analysts C-Rad AB Class B’s price is currently Overvalued.
Does C-Rad AB Class B pay dividends?
C-Rad AB Class B does not currently pay dividends.
What is C-Rad AB Class B’s EPS estimate?
C-Rad AB Class B’s EPS estimate is 0.03.
How many shares outstanding does C-Rad AB Class B have?
C-Rad AB Class B has 32,904,050 shares outstanding.
What happened to C-Rad AB Class B’s price movement after its last earnings report?
C-Rad AB Class B reported an EPS of €0.03 in its last earnings report, beating expectations of €0.014. Following the earnings report the stock price went up 32.471%.
Which hedge fund is a major shareholder of C-Rad AB Class B?
Currently, no hedge funds are holding shares in DE:24C
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
C-Rad AB Class B
C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a surface image guided radiation therapy solution that supports proton therapy from simulation to treatment; Catalyst+ HD Ring Gantry solution for patient positioning, real-time motion monitoring, and respiratory gating; and Sentinel 4DCT, a laser-based optical surface scanning system. It also provides Catalyst, a 4D surface guided radiation therapy (SGRT) solution; Catalyst HD, a SGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst PT, a tracking solution for particle therapy; and visual coaching solutions used for prospective and retrospective radiotherapy. In addition, the company offers cAutoVerify, an automation solution for the imaging suite and treatment room, automating patient identity validation, and accessory tracking; and cAccessory, which automates the registration and validation of treatment accessories. Further, it provides SmartPhantom RT, a device that allows automatic adjustment and alignment of fixed lasers with motorization; StaticPhantom, a set-up used to visually verify the precision of the alignment of lasers; high impact technology motorized system, a laser positioning system; HIT Single Diode; and HIT1, HIT3, and HIT5 patient positioning laser, as well as laser positioning products and solutions. Additionally, the company offers support and training services; and service contracts. C-Rad AB (publ) was incorporated in 2004 and is headquartered in Uppsala, Sweden.
Technical Analysis
Paxman AB
―
Senzime AB
―
Bactiguard Holding AB
―
Integrum AB Class B
―
Sedana Medical AB
―